Shape rather than smoothing. Firm hyaluronic acid gel placed against bone at the cheek, chin and jawline.
Book a consultationShape built at bone
Facial contouring is filler that changes the shape of the face rather than softening a line. Firm hyaluronic acid gel is placed against bone at the cheek, chin and jawline. Most plans use 2 to 4 syringes, and midface results last 12 to 18 months.
Most people who ask about contouring want the shape changed, not a line softened. Structural filler placed on or near bone does that.
What changes is the edge your face is built on. A firm gel against the periosteum, the living sheath over bone, holds that edge. Your bone sets the range.
| Region | Typical product family | Typical volume | Typical duration | FDA label status |
|---|---|---|---|---|
| Cheek and midface | Juvéderm® Voluma® XC, Restylane® Contour or Lyft | 1 to 2 mL per side | 12 to 18 months | On-label for cheek augmentation and midface volume or contour deficiency in adults over 21 |
| Chin projection | Juvéderm® Voluma® XC, Restylane® Defyne | 1 to 2 mL total | Up to about 12 months | On-label for chin augmentation to correct retrogenia, adults over 21 |
| Jawline and angle | Juvéderm® Volux® XC, or other firm gels | 2 to 4 mL total | 12 months labelled; 12 to 18 months typical in practice | On-label with Volux® XC, off-label with other gels |
| Temple | Juvéderm® Voluma® XC, Restylane® Lyft | 0.5 to 1 mL per side | About 12 months | On-label with Juvéderm® Voluma® XC; off-label with Restylane® Lyft |
Find the row for the region driving the appearance — the four regions differ in product, volume, duration and FDA label status, so one row rarely stands in for another. Durations reflect product labelling and practice observation. Individual results vary.
Juvéderm® Voluma® XC — FDA-approved for deep injection in the cheek for age-related midface volume deficit, and for chin augmentation to correct retrogenia, meaning a chin that sits back behind the lower lip, in adults over 21. Firm and cohesive, so it holds an edge at depth.
Juvéderm® Volux® XC — FDA-approved for improvement of jawline definition in adults over 21. It is the firmest gel in that family by the manufacturer's own specification, which is why it is reserved for the bony border rather than for soft tissue.
Restylane® Lyft and Restylane® Contour — Both are FDA-approved for cheek augmentation and the correction of midface contour deficiencies in adults over 21; the Restylane® Lyft indication is worded for age-related deficiency. Restylane® Contour is built to flex with an animated midface; Lyft is firmer and more granular. That is a handling difference, not a ranking.
Restylane® Defyne — FDA-approved for chin augmentation to correct retrogenia in adults over 21. Chosen when flexibility at the chin matters more than maximum firmness.
Hyaluronidase — Held on site at every filler appointment, and itself a prescription drug carrying its own allergy risk. It is what makes contouring with hyaluronic acid a largely reversible decision, and the reason biostimulators are treated as a slower one.
Sculptra® — Poly-L-lactic acid stimulates the patient's own collagen rather than filling, and hyaluronidase will not dissolve it. Its FDA approval covers facial wrinkles and folds, so volumising the midface and temple with it is off-label, which is why it runs at a smaller dose and on a longer timeline than structural filler.
We read your face together, front and profile, then review medications, bleeding risk, prior filler and dental work.
You see the order first: region one read at two weeks, region two four to six weeks later.
Placement is the shortest part. Product goes in against bone, in small increments, by needle or cannula.
Ask about follow-up timing, contact arrangements, and any additional charges before treatment.
Swelling peaks at 24 to 72 hours.
Shape is visible the same day. Give it two weeks before you judge it. Plans are staged across two visits, four to six weeks apart.
Most contouring plans use 2 to 4 syringes, staged across two visits. A chin alone often takes 1 to 2 mL, a midface 1 to 2 mL per side, and a jawline 2 to 4 mL.
They overlap. Facial contouring is the structural half: it changes the shape of the cheek, chin and jaw with firm filler placed against bone. Balancing is the wider assessment that decides proportion across the whole face, including movement and soft tissue, and it can conclude that no filler is indicated at all. You do not have to know which one you want before you come.
It can, if the product is placed laterally or in too large a volume. Product set high and forward on the zygomatic body reads as projection; the same gel spread towards the ear reads as width.
Sometimes, yes. A young face with good midface support is a reasonable single-region plan. Often the border looks soft because support was lost above it, and defining an edge under descending tissue makes the lower face heavier.
Midface filler typically lasts 12 to 18 months. The chin and jawline gels are labelled for up to about 12 months, and the jaw reads shorter because it moves with speech and chewing.
Most patients describe pressure rather than sharp pain, since the product is placed against bone. You are numbed twice: topical anesthetic for about 20 minutes, then lidocaine in the gel. The chin and jaw angle are tender.
Hyaluronic acid has an antidote, and it is in the room: hyaluronidase breaks the gel into fragments your body clears. Worth knowing: dissolving is not instant, not perfectly selective, and sometimes takes more than one session. So a first visit places the smaller volume.
Some of it, and you hear which parts before you consent to anything. Cheek augmentation with Juvéderm® Voluma® XC, Restylane® Lyft and Restylane® Contour, and chin augmentation with Juvéderm® Voluma® XC and Restylane® Defyne, are FDA-approved indications in adults over 21, and Juvéderm® Volux® XC is FDA-approved for jawline definition in adults over 21. Juvéderm® Voluma® XC holds a US indication for temple hollowing in adults over 21, so the temple is on-label for that gel and off-label for every other gel named here. Jawline placement with gels other than Juvéderm® Volux® XC, and contouring with Sculptra®, are off-label. Off-label means the FDA approved the product, but not for that particular use: the product is the same, and that placement has not been through the approval process. Off-label use is legal and common in medicine, and each off-label placement is named on the written plan before consent.
Common: bruising, swelling, tenderness, small lumps settling within two weeks. Less common: asymmetry, infection, or a nodule weeks to months later. Rare and serious: vascular occlusion, where filler enters a blood vessel and cuts off the blood supply to the skin it feeds, which can cause skin loss or, very rarely, vision loss that may not recover. Cannulas, hyaluronidase and a written protocol lower that risk rather than remove it. Prescribed blood thinners are not stopped for a cosmetic treatment.
Ask about follow-up timing, contact arrangements, and any additional charges before treatment.
This page is general information about facial contouring, not medical advice, and not a substitute for an in-person evaluation. Treatment requires a consultation and a medical eligibility review, and treatment is not offered where it is not indicated.
Individual results vary. Nothing here is a promise of a specific result. Temple placement is on-label with Juvéderm® Voluma® XC in adults over 21 and off-label with every other gel named here. Jawline placement with gels other than Juvéderm® Volux® XC, and contouring placement of Sculptra®, are off-label uses. Off-label use is legal and common in medicine, and the status of each product used is stated again at consultation.
Juvéderm®, Voluma® and Volux® are registered trademarks of Allergan Aesthetics, an AbbVie company. Restylane® and Sculptra® are registered trademarks of Galderma. Kybella® is a registered trademark of Allergan, Inc. Rouge Aesthetics is not affiliated with or endorsed by those companies.
Rouge Aesthetics · 101 Mill Street, Suite 210, Gahanna, OH 43230 · (614) 425-1633
Individual results vary. This website provides general information and does not replace an individual consultation.